SENSEX NIFTY

Sanofi Aventis

Sep 23, 2013 at 09:56 | Source: Moneycontrol.com
Genzyme, a fully-owned subsidiary of drug major Sanofi-Aventis, alleged that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.
Sep 22, 2013 at 13:58 | Source: PTI
In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with US FDA seeking approval to engage in the commercial manufacture, importation, use, and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil drug.
Sep 16, 2013 at 15:54 | Source: Moneycontrol.com
Pharma major, Lupin, announced today that it has received final approval for its Zolpidem Tartrate Extended-release tablets USP, 6.25 mg and 12.5 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Sanofi Aventis, US, LLCs (Sanofi) Ambien CR Extended-release tablets, 6.25 mg and 12.5 mg.
Jun 26, 2013 at 18:46 | Source: Moneycontrol.com
The stock hit 5 percent upper circuit limit on Wednesday following a report that companies like Sanofi Aventis, Novartis and GlaxoSmithKline were in the race to buy out the company's domestic formulations business.
Jun 26, 2013 at 12:12 | Source: Moneycontrol.com
The report states that Sanofi and GSK have put in non-binding bids and Novartis has signed a non-disclosure agreement to acquire the domestic formulations business of Elder Pharma.
Jun 16, 2013 at 21:30 | Source: PTI
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Feb 19, 2013 at 22:31 | Source: PTI
Sanofi India (previously known as Aventis Pharma) on Tuesday said it aims to double its consumer healthcare business in the next five years
Feb 15, 2013 at 15:43 | Source: Moneycontrol.com
The Andhra Pradesh High Court (HC) today said that French drug giant Sanofi Aventis need not pay capital gain tax as demanded by Income Tax (I-T) department for acquisition of Shantha Biotech in 2009.
Oct 17, 2012 at 15:00 | Source: PTI
Pharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration to market a generic version of Sanofi Aventis's Avapro tablets.
Oct 17, 2012 at 14:51 | Source: PTI
Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.